163 related articles for article (PubMed ID: 1970295)
1. Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2-adrenergic receptors involves multiple subsites.
Marullo S; Emorine LJ; Strosberg AD; Delavier-Klutchko C
EMBO J; 1990 May; 9(5):1471-6. PubMed ID: 1970295
[TBL] [Abstract][Full Text] [Related]
2. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors.
Frielle T; Daniel KW; Caron MG; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9494-8. PubMed ID: 2849109
[TBL] [Abstract][Full Text] [Related]
4. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
Guan XM; Amend A; Strader CD
Mol Pharmacol; 1995 Sep; 48(3):492-8. PubMed ID: 7565630
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.
Roy KK; Saxena AK
J Chem Inf Model; 2011 Jun; 51(6):1405-22. PubMed ID: 21534556
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
7. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.
Green SA; Cole G; Jacinto M; Innis M; Liggett SB
J Biol Chem; 1993 Nov; 268(31):23116-21. PubMed ID: 7901205
[TBL] [Abstract][Full Text] [Related]
8. Characterization of beta-adrenoceptors responsible for venom production in the venom gland of the snake Bothrops jararaca.
Yamanouye N; Carneiro SM; Scrivano CN; Markus RP
Life Sci; 2000 Jun; 67(3):217-26. PubMed ID: 10983865
[TBL] [Abstract][Full Text] [Related]
9. Properties of the beta 1- and beta 2-adrenergic receptor subtypes revealed by molecular cloning.
Frielle T; Caron MG; Lefkowitz RJ
Clin Chem; 1989 May; 35(5):721-5. PubMed ID: 2541947
[TBL] [Abstract][Full Text] [Related]
10. Structure-binding-activity analysis of beta-adrenergic amines--II. Binding to the beta receptor and inhibition of adenylate cyclase.
Bilezikian JP; Dornfeld AM; Gammon DE
Biochem Pharmacol; 1978 May; 27(10):1455-61. PubMed ID: 29639
[No Abstract] [Full Text] [Related]
11. Atypical beta-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptor.
Fève B; Emorine LJ; Lasnier F; Blin N; Baude B; Nahmias C; Strosberg AD; Pairault J
J Biol Chem; 1991 Oct; 266(30):20329-36. PubMed ID: 1682311
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists.
Furse KE; Lybrand TP
J Med Chem; 2003 Oct; 46(21):4450-62. PubMed ID: 14521408
[TBL] [Abstract][Full Text] [Related]
13. The binding of agonists and antagonists to rat lung beta-adrenergic receptors as investigated by thermodynamics and structure-activity relationships.
Bree F; el Tayar N; Van de Waterbeemd H; Testa B; Tillement JP
J Recept Res; 1986; 6(5-6):381-409. PubMed ID: 2884310
[TBL] [Abstract][Full Text] [Related]
14. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.
Weiland GA; Minneman KP; Molinoff PB
Nature; 1979 Sep; 281(5727):114-7. PubMed ID: 38405
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
Contreras ML; Wolfe BB; Molinoff PB
J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
[TBL] [Abstract][Full Text] [Related]
16. Evidence of classic beta 3-adrenergic receptors in porcine adipocytes.
Mersmann HJ
J Anim Sci; 1996 May; 74(5):984-92. PubMed ID: 8726730
[TBL] [Abstract][Full Text] [Related]
17. A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains.
Meng F; Hoversten MT; Thompson RC; Taylor L; Watson SJ; Akil H
J Biol Chem; 1995 May; 270(21):12730-6. PubMed ID: 7759527
[TBL] [Abstract][Full Text] [Related]
18. Leutropin/beta-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface.
Moyle WR; Bernard MP; Myers RV; Marko OM; Strader CD
J Biol Chem; 1991 Jun; 266(17):10807-12. PubMed ID: 1645710
[TBL] [Abstract][Full Text] [Related]
19. A truncation mutation in the avian beta-adrenergic receptor causes agonist-induced internalization and GTP-sensitive agonist binding characteristic of mammalian receptors.
Hertel C; Nunnally MH; Wong SK; Murphy EA; Ross EM; Perkins JP
J Biol Chem; 1990 Oct; 265(29):17988-94. PubMed ID: 1976632
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes.
Niclauss N; Michel-Reher MB; Alewijnse AE; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):99-105. PubMed ID: 17028849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
